Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Brittle cornea syndrome ZNF469 mutation carrier phenotype and segregation analysis of rare ZNF469 variants in familial keratoconus

AE. Davidson, E. Borasio, P. Liskova, AO. Khan, H. Hassan, ME. Cheetham, V. Plagnol, FS. Alkuraya, SJ. Tuft, AJ. Hardcastle,

. 2015 ; 56 (1) : 578-86.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15022875

PURPOSE: Brittle cornea syndrome 1 (BCS1) is a rare recessive condition characterized by extreme thinning of the cornea and sclera, caused by mutations in ZNF469. Keratoconus is a relatively common disease characterized by progressive thinning and ectasia of the cornea. The etiology of keratoconus is complex and not yet understood, but rare ZNF469 variants have recently been associated with disease. We investigated the phenotype of BCS1 carriers with known pathogenic ZNF469 mutations, and recruited families in which aggregation of keratoconus was observed to establish if rare variants in ZNF469 segregated with disease. METHODS: Patients and family members were recruited and underwent comprehensive anterior segment examination, including corneal topography. Blood samples were donated and genomic DNA was extracted. The coding sequence and splice sites of ZNF469 were PCR amplified and Sanger sequenced. RESULTS: Four carriers of three BCS1-associated ZNF469 loss-of-function mutations (p.[Glu1392Ter], p.[Gln1930Argfs*6], p.[Gln1930fs*133]) were examined and none had keratoconus. One carrier had partially penetrant features of BCS1, including joint hypermobility. ZNF469 sequencing in 11 keratoconus families identified 9 rare (minor allele frequency [MAF] ≤ 0.025) variants predicted to be potentially damaging. However, in each instance the rare variant(s) identified, including two previously reported as potentially keratoconus-associated, did not segregate with the disease. CONCLUSIONS: The presence of heterozygous loss-of-function alleles in the ZNF469 gene did not cause keratoconus in the individuals examined. None of the rare nonsynonymous ZNF469 variants identified in the familial cohort conferred a high risk of keratoconus; therefore, genetic variants contributing to disease pathogenesis in these 11 families remain to be identified.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15022875
003      
CZ-PrNML
005      
20150729113344.0
007      
ta
008      
150709s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1167/iovs.14-15792 $2 doi
035    __
$a (PubMed)25564447
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Davidson, Alice E $u UCL Institute of Ophthalmology, London, United Kingdom.
245    10
$a Brittle cornea syndrome ZNF469 mutation carrier phenotype and segregation analysis of rare ZNF469 variants in familial keratoconus / $c AE. Davidson, E. Borasio, P. Liskova, AO. Khan, H. Hassan, ME. Cheetham, V. Plagnol, FS. Alkuraya, SJ. Tuft, AJ. Hardcastle,
520    9_
$a PURPOSE: Brittle cornea syndrome 1 (BCS1) is a rare recessive condition characterized by extreme thinning of the cornea and sclera, caused by mutations in ZNF469. Keratoconus is a relatively common disease characterized by progressive thinning and ectasia of the cornea. The etiology of keratoconus is complex and not yet understood, but rare ZNF469 variants have recently been associated with disease. We investigated the phenotype of BCS1 carriers with known pathogenic ZNF469 mutations, and recruited families in which aggregation of keratoconus was observed to establish if rare variants in ZNF469 segregated with disease. METHODS: Patients and family members were recruited and underwent comprehensive anterior segment examination, including corneal topography. Blood samples were donated and genomic DNA was extracted. The coding sequence and splice sites of ZNF469 were PCR amplified and Sanger sequenced. RESULTS: Four carriers of three BCS1-associated ZNF469 loss-of-function mutations (p.[Glu1392Ter], p.[Gln1930Argfs*6], p.[Gln1930fs*133]) were examined and none had keratoconus. One carrier had partially penetrant features of BCS1, including joint hypermobility. ZNF469 sequencing in 11 keratoconus families identified 9 rare (minor allele frequency [MAF] ≤ 0.025) variants predicted to be potentially damaging. However, in each instance the rare variant(s) identified, including two previously reported as potentially keratoconus-associated, did not segregate with the disease. CONCLUSIONS: The presence of heterozygous loss-of-function alleles in the ZNF469 gene did not cause keratoconus in the individuals examined. None of the rare nonsynonymous ZNF469 variants identified in the familial cohort conferred a high risk of keratoconus; therefore, genetic variants contributing to disease pathogenesis in these 11 families remain to be identified.
650    _2
$a dospělí $7 D000328
650    _2
$a rohovková topografie $7 D019781
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a Ehlersův-Danlosův syndrom $x genetika $x patologie $7 D004535
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a heterozygot $7 D006579
650    _2
$a lidé $7 D006801
650    _2
$a keratokonus $x genetika $x patologie $7 D007640
650    _2
$a mužské pohlaví $7 D008297
650    12
$a mutace $7 D009154
650    _2
$a rodokmen $7 D010375
650    _2
$a fenotyp $7 D010641
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a transkripční faktory $x genetika $7 D014157
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Borasio, Edmondo $u Moorfields Eye Hospital, Al Razi Building, Dubai Healthcare City, Dubai, United Arab Emirates.
700    1_
$a Liskova, Petra $u Moorfields Eye Hospital, London, United Kingdom Institute of Inherited Metabolic Diseases and First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic.
700    1_
$a Khan, Arif O $u Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
700    1_
$a Hassan, Hala $u Moorfields Eye Hospital, London, United Kingdom.
700    1_
$a Cheetham, Michael E $u UCL Institute of Ophthalmology, London, United Kingdom.
700    1_
$a Plagnol, Vincent $u UCL Genetics Institute, London, United Kingdom.
700    1_
$a Alkuraya, Fowzan S $u Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. $7 gn_A_00004370
700    1_
$a Tuft, Stephen J $u UCL Institute of Ophthalmology, London, United Kingdom Moorfields Eye Hospital, London, United Kingdom.
700    1_
$a Hardcastle, Alison J $u UCL Institute of Ophthalmology, London, United Kingdom.
773    0_
$w MED00002404 $t Investigative ophthalmology & visual science $x 1552-5783 $g Roč. 56, č. 1 (2015), s. 578-86
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25564447 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20150729113430 $b ABA008
999    __
$a ok $b bmc $g 1083214 $s 905868
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 56 $c 1 $d 578-86 $i 1552-5783 $m Investigative ophthalmology & visual science $n Invest Ophthalmol Vis Sci $x MED00002404
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace